Abstract
Clinical trials and research are a very involved and often lengthy process with formalities and regulations that should be adhered to. There are questions over the transparency of clinical research data from the start of the initial process of registration, informed consent, clinical outcomes and to where approval is given by post marketing and publication. These impacts suggested have manifested itself in the form of fraud, misconduct, selective reporting, bias and consequently had other effects to those taking approved drugs; some resulting in fatalities. Access to research data has also been difficult to obtain from those involved in the clinical trials such as patients and even researchers whom would be interested in the post marketing phase and pharmaceutical analysis. Evidence is presented with data extracted from credible sources that highlight the concerns in registration, informed consent and clinical research outcomes and how they are reported with recent example of how opioids misuse has ended up as a serious issue as a consequence of non-transparency. This Chapter suggests a theoretical model to propose how blockchain could present a more transparent and secure method to tackle the issues mentioned, with utilising blockchain as the mechanism/framework for clinical research institutions, regulation and non-regulation bodies, pharmaceutical organisations, drug manufacturers/suppliers and patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AllTrials (2013) GSK statement. [Online]. Available at http://www.alltrials.net/supporters/organisations/gsk-statement/. Accessed 30 May 2018
Bellon T (2018) U.S. state lawsuits against Purdue Pharma over opioid epidemic mount. [Online]. Available at https://www.reuters.com/article/us-usa-opioids-litigation/u-s-state-lawsuits-against-purdue-pharma-over-opioid-epidemic-mount-idUSKCN1IG2WU. Accessed 16 June 2018
Benchoufi M, Ravaud P (2017) Blockchain technology for improving clinical research quality. Trials 18:335. Available at https://doi.org/10.1186/s13063-017-2035-z. Accessed 20 Oct 2018
Bourgeois F, Murthy S, Mandl KD, (2010) Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 153(3):158–166. Available at https://doi.org/10.7326/0003-4819-153-3-201008030-00006. Accessed 20 Oct 2018
ClinicalTrials.gov (2018) Trends, charts and map. [Online]. Available at https://clinicaltrials.gov/ct2/resources/trends. Accessed 1 June 2018
Cohen D (2018a) The opioid timebomb. [Online]. Available at https://opioids.standard.co.uk/#article. Accessed 16 June 2018
Cohen D (2018b) The opioid timebomb: how addiction to painkillers cost me my wife, my children, my home and my £150,000-a-year job. [Online]. Available at https://www.standard.co.uk/news/uk/the-opioid-timebomb-how-addiction-to-painkillers-cost-me-my-wife-my-children-my-home-and-my-a3791006.html. Accessed 16 June 2018
COMPare Trials Project (2016) Goldacre B, Drysdale H, Powell-Smith A., et al. www.COMPare-trials.org. [Online]. Available at http://compare-trials.org/results. Accessed 1 June 2018
DrugPatentWatch (2017) Can blockchain technology put an end to counterfeit drugs. [Online]. Available at https://medium.com/drugpatentwatch/can-blockchain-technology-put-an-end-to-counterfeit-drugs-c4087e652fe0. Accessed 20 Oct 2018
Engelhardt M (2017) Hitching healthcare to the chain: an introduction to blockchain technology in the healthcare sector. Technol Innov Manag Rev 7(10): 22–34. Available at https://doi.org/10.22215/timreview/1111. Accessed 20 Oct 2018
Goldacre B (2013) Are clinical trial data shared sufficiently today? No. BMJ, Br Med J (online) 347: 1–3. Available at https://doi.org/10.1136/bmj.f1880. Accessed 20 Oct 2018
Gupta A (2013) Fraud and misconduct in clinical research: a concern. Perspect Clin Res 4(2). Available at https://doi.org/10.4103/2229-3485.111800. Accessed 20 Oct 2018
Hurley R (2017) Drugs caused record number of deaths in England and Wales in 2016. BMJ, Br Med J 358. [Online]. Available at https://search.proquest.com/docview/1925754408?accountid=12860. https://doi.org/10.1136/bmj.j3750. Accessed 16 June 2018
Liang X, et al (2017) Integrating blockchain for data sharing and collaboration in mobile healthcare applications. 2017 IEEE 28th annual international symposium on personal, indoor, and mobile radio communications (PIMRC), Montreal, QC, pp 1–5. Available at https://doi.org/10.1109/PIMRC.2017.8292361. Accessed 20 Oct 2018
Logvinov V (2014) Clinical trials transparency and the trial and experimental studies transparency (TEST) act. Contemp Clin Trials 37(2): 219–224. Available at https://doi.org/10.1016/j.cct.2014.01.001. Accessed 20 Oct 2018
Matthews-King A (2018) Breast cancer screening: 450,000 women missed out on checkup invitations due to IT error, Jeremy Hunt admits. [Online]. Available at https://www.independent.co.uk/news/health/jeremy-hunt-breast-cancer-screening-inquiry-nhs-women-invitations-missing-a8332446.html. Accessed 18 June 2018
Moore A et al (2013) Expect analgesic failure; pursue analgesic success. BMJ, Br Med J (Online) 346. Available at https://search.proquest.com/docview/1945757929?accountid=12860. https://doi.org/10.1136/bmj.f2690. Accessed 16 June 2018
National Center for Biotechnology Information (2018) [Online]. Available at https://www.ncbi.nlm.nih.gov/. Accessed 20 Oct 2018
Prayle A, Hurley M, Smyth A (2012) Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ, Br Med J 344. [Online]. Available at https://doi.org/10.1136/bmj.d7373. Accessed 20 Oct 2018
Proehl J, Hoyt S (2017) Integrity and transparency in reporting clinical trials. Adv Emerg Nurs J 39(1): 1–2. Available at https://doi.org/10.1016/j.jen.2017.01.009. Accessed 20 Oct 2018
Public Eye (2013) Clinical trials. [Online]. Available at https://www.publiceye.ch/en/topics-background/health/clinical-trials/. Accessed 20 Oct 2018
RamÃrez J (2013) Lack of transparency in clinical trials: a call for action. Colomb Méd, CM 44(4): 243–246. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002000/. Accessed 20 Oct 2018
Ross J, Gross C, Krumholz H (2012) Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health 102(1): 72–80 Available at https://doi.org/10.2105/AJPH.2011.300187. Accessed 20 Oct 2018
Seife C (2015) Research misconduct identified by the US Food and Drug Administration. [Online]. Available at https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2109855?alert=article. Accessed 10 June 2018
Song F, et al (2010) Dissemination and publication of research findings: an updated review of related basics. Health Technol Assess 14(8). Available at https://doi.org/10.3310/hta1480. Accessed 20 Oct 2018
Viergever RF, Ghersi D (2011) The quality of registration of clinical trials. PLoS One 6(2). Available at http://dx.plos.org/10.1371/journal.pone.0014701. Accessed 10 June 2018
Viergever R, Karam G, Reis A, Ghersi D (2014) The quality of registration of clinical trials: still a problem. PLoS One 9(1): 1–12. Available at https://doi.org/10.1371/journal.pone.0084727. Accessed 20 Oct 2018
Wager E et al (2013) Hardly worth the effort? Medical journals’ policies and their editors’ and publishers’ views on trial registration and publication bias: quantitative and qualitative study. BMJ 347: f524. Available at https://doi.org/10.1136/bmj.f5248. Accessed 10 June 2018
Zarin D et al (2011) The ClinicalTrials.gov results database—update and key issues. N Engl J Med 3;364(9): 852–860. Available at https://doi.org/10.1056/NEJMsa1012065. Accessed 20 Oct 2018
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kendzierskyj, S., Jahankhani, H. (2019). Healthcare Patient and Clinical Research. In: Jahankhani, H., Kendzierskyj, S., Jamal, A., Epiphaniou, G., Al-Khateeb, H. (eds) Blockchain and Clinical Trial. Advanced Sciences and Technologies for Security Applications. Springer, Cham. https://doi.org/10.1007/978-3-030-11289-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-11289-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11288-2
Online ISBN: 978-3-030-11289-9
eBook Packages: Computer ScienceComputer Science (R0)